Medical convenience kits containing BD CliniClean Pericare Wipes within BD Urinary Catheter Trays...
FDA Device Recall #Z-3294-2026 - Class II, August 10, 2026
Recall Summary
| Recall Number | Z-3294-2026 |
| Classification | Class II - Moderate risk |
| Date Initiated | August 10, 2026 |
| Status | Ongoing |
| Voluntary | Voluntary: Firm initiated |
Recalling Firm
| Firm | American Contract Systems Inc |
| Location | Tiffin, OH |
| Product Type | Devices |
| Quantity | 1,804 kits total |
Product Description
Medical convenience kits containing BD CliniClean Pericare Wipes within BD Urinary Catheter Trays ABDOMINAL HYSTERECTOMY - 205989 Model No. MHAH55AM LAVH-LAP COLON Model No. SPLL54U VAG HYST PACK Model No. SPVH62P
Reason for Recall
Kits contain manufacturer-recalled perineal care (pericare) wipes within urinary catheter trays, which may be contaminated with a lubricant used during the manufacturing process. Use of a contaminated wipe may lead to localized skin effects such as irritation, erythema, or mild inflammation. Failure to perform pericare due to disposal of contaminated wipes may increase risk of localized infection or catheter-associated urinary tract infection (CAUTI).
Distribution Pattern
US Nationwide distribution in the states of Iowa, Minnesota, Wisconsin, and South Dakota.
Lot / Code Information
MHAH55AM UDI-DI 191072236487 Lots 42-8529911 42-8649211 42-8687711 42-8797811 42-8857011 42-8869711 SPLL54U UDI-DI 191072239181 Lots 07-2516111 07-2528611 07-2545611 07-2547911 07-2561411 SPVH62P UDI-DI 191072238771 Lots 07-2544611 12-7436711
Other Recalls from American Contract Systems Inc
| Recall # | Classification | Product | Date |
|---|---|---|---|
| Z-3293-2026 | Class II | Medical convenience kits containing BD CliniCle... | Aug 10, 2026 |
| Z-3292-2026 | Class II | Medical convenience kits containing BD CliniCle... | Aug 10, 2026 |
| Z-3003-2026 | Class II | American Contract System Convenience Kit, D & C... | Jun 29, 2026 |
| Z-3001-2026 | Class II | American Contract System Convenience Kit, CV B ... | Jun 29, 2026 |
| Z-3002-2026 | Class II | American Contract System Convenience Kits, CV B... | Jun 29, 2026 |
Frequently Asked Questions
Sterility recalls for medical devices vary in severity. If you have already had a procedure using a potentially non-sterile device, contact your healthcare provider immediately, you may need monitoring for signs of infection. Symptoms to watch for include fever, redness or swelling at the surgical site, unusual pain, or discharge. For devices that have not yet been used, they should be quarantined and returned to the manufacturer per the recall notice. Non-sterile implants can cause serious infections; early detection and treatment are critical.
Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency, Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.
Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.
What Should You Do?
Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.